# Research Problem

## Motivation

Deep learning systems for computational pathology commonly require
substantial quantities of expert-labeled data.

Histopathology annotation is expensive and time-consuming because
reliable labeling requires domain expertise.

Semi-supervised learning provides a possible solution by combining
a small labeled subset with a much larger unlabeled dataset.

## Research Question

Can semi-supervised adversarial learning maintain useful
histopathology classification performance when only a small fraction
of the available training data is labeled?

## Proposed Approach

SemiGAN-MelanoPath investigates a hybrid learning framework combining:

1. Supervised classification
2. Virtual Adversarial Training
3. Self-supervised rotation prediction
4. Adversarial representation learning
5. Feature matching
6. Uncertainty estimation

## Experimental Questions

### E1 — Label Scarcity

How does performance change as the labeled fraction decreases?

### E2 — Cross-Domain Transfer

Can representations learned from one histopathology domain transfer
to another domain?

### E3 — Annotation Budget

How much expert annotation can potentially be reduced?

### E4 — Ablation

Which components contribute most to the final performance?

### E5 — Uncertainty

Can uncertainty estimation identify predictions that should be
reviewed by a human expert?

## Reproducibility

All experiments will use fixed random seeds, patient-level data
splits where patient identifiers are available, predefined
configurations, and multiple experimental seeds.